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CHO cells primarily utilize amino acids for three processes: biomass synthesis, recombinant protein production and catabolism. In 
this work, we disrupted 9 amino acid catabolic genes participating in 7 dierent catabolic pathways, to increase synthesis of biomass 
and recombinant protein, while reducing production of growth-inhibiting metabolic by-products from amino acid catabolism. 
Key message
Overview of experimentsBackground
Conclusion
Physiology of single gene disrupted CHO cells
Disruption of single amino acid catabolic pathways in CHO cells reduces specic production of 
lactate and ammonium, while increasing µmax and IVCD, leading to increased titers of recombi-
nant proteins. Disruption of multiple catabolic pathways further reduces secretion of lactate 
and ammonium, but does not increase growth. Thus, we recommend combinatorial disruption 
of multiple amino acid catabolic pathways, to identify a set of disruptions that increase growth, 
while reducing secretion of lactate and ammonium. 
To study the physiological impact of disrupting single amino acid catabolic pathways, we char-
acterized single gene disrupted clones in triplicate shake ask cultures in batch mode. We moni-
tored physiological changes in terms of maximum specic growth rate (µmax), integral of viable 
cell density (IVCD) and secretion of lactate and ammonium.
To exclude that the improved phenotypes are caused by clonal variation, we characterized mul-
tiple clones with dierent mutations in gene 4 and 6, and found a strong link between genotype 
and phenotype.
To investigate the impact of EPO production on metabolism, we reconstructed glycolysis, TCA and 
amino acid catabolism in CHO cells (see link below) and integrated dierential gene expression data 
from phase II of chemostat culture. The data integration revealed decreased transcription level of 
genes responsible for degradation of the amino acids most frequently found in EPO. Thus, indicating 
possible regulatory adaptation of gene expression towards decreased amino acid catabolism, spe-
cic for the most abundant amino acids in EPO, in the high producer relative to the low producer.
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Amino acid catabolism produces a wide range of growth inhibiting compounds1, amongst 
these ammonium and lactate. Ammonium is produced by transamination and deamination re-
actions2, whereas lactate is produced by either amino acid catabolic pathways fueling glycolysis 
or by NADH producing catabolic pathways, which forces the cell to regenerate NAD+ through 
lactate synthesis3. Disruption of amino acid catabolic pathways may reduce production of 
growth-inhibiting metabolic by-products.
Validation of functional gene knock-out
Physiology of multiple gene disrupted CHO cells
Target genes were identied using a metabolic network reconstruction of amino acid catabo-
lism4. Gene knock-out was performed with CRISPR-Cas9. Single cells expressing GFP-linked 
Cas9 were enriched on FACS. Physiology of gene-edited clones was assessed in shake flasks and 
bioreactors. Phenotypes were validated by targeted genome sequencing, qRT-PCR, western 
blot and proteomic analysis.
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Functional gene disruptions were validated using deep sequencing of the targeted genomic 
loci, gene expression analysis, western blots and proteomics. All genes displayed out-of-frame 
mutations (A) and generally reduced transcription (B). Western blots indicated potential wild 
type proteins in some clones (C), so proteomic analysis and mRNA sequencing was applied to 
verify functional knock-out of target genes (ongoing work).
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Single gene disrupted clones generally showed an increased growth phenotype with 8 of 9 
clones displaying increased µmax (up to 115% of WT), while 6 of 9 clones had increased IVCD (up 
to 136% of WT). Specic secretion of lactate was reduced in 4 of 9 clones (down to 81% of WT), 
while specic secretion of ammonium was reduced in 5 of 9 clones (down to 91% of WT). Mono-
clonal antibody titers increased proportionally to IVCD (data not shown). 
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To explore potential synergistic eects of disrupting multiple pathways, we targeted gene 1-4 
for knock-out, but did not achieve full knock-out of all genes. Still, we isolated two clones with 
interesting genotypes. Clones were characterized in duplicated bioreactor cultures and showed 
further reduced lactate and ammonium secretion, but no growth benet. 
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Figure graphics were modied from5..
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